• レポートコード:MRC2-11QY11889 • 出版社/出版日:QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、93ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:ヘルスケア |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は真核生物発現システムのグローバル市場について調査・分析したレポートです。種類別(MEL、COS、CHO、昆虫細胞)市場規模、用途別(試薬、発現ベクター、コンピテントセル)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別真核生物発現システムの競争状況、市場シェア ・世界の真核生物発現システム市場:種類別市場規模 2015年-2020年(MEL、COS、CHO、昆虫細胞) ・世界の真核生物発現システム市場:種類別市場規模予測 2021年-2026年(MEL、COS、CHO、昆虫細胞) ・世界の真核生物発現システム市場:用途別市場規模 2015年-2020年(試薬、発現ベクター、コンピテントセル) ・世界の真核生物発現システム市場:用途別市場規模予測 2021年-2026年(試薬、発現ベクター、コンピテントセル) ・北米の真核生物発現システム市場分析:米国、カナダ ・ヨーロッパの真核生物発現システム市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの真核生物発現システム市場分析:日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の真核生物発現システム市場分析:メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの真核生物発現システム市場分析:トルコ、サウジアラビア、UAE等 ・企業情報(企業概要、製品概要、販売量、企業動向) - 掲載企業(変更可能性あり):Thermo Fisher、Sigma Aldrich、Jena Bioscience、New England Biolabs、Takara Bio、Bio Rad、Promega、Agilent、Merck Millipore ・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Expression systems are used for the production of protein from recombinant DNA molecules (see Recombinant Proteins). They are of widespread use in industry, health care, and scientific research
Increasing cases of complex diseases such as cancer & other cardiovascular diseases and increasing research & development for therapeutics for such diseases are the main drivers of the growth of the market
Market Analysis and Insights: Global Eukaryotic Expression Systems Market
The global Eukaryotic Expression Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Eukaryotic Expression Systems Scope and Market Size
Eukaryotic Expression Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Eukaryotic Expression Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Thermo Fisher
Sigma Aldrich
Jena Bioscience
New England Biolabs
Takara Bio
Bio Rad
Promega
Agilent
Merck Millipore
Market segment by Type, the product can be split into
MEL
COS
CHO
Insect cells
Market segment by Application, split into
Reagents
Expression vectors
Competent cells
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Eukaryotic Expression Systems Revenue
1.4 Market by Type
1.4.1 Global Eukaryotic Expression Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 MEL
1.4.3 COS
1.4.4 CHO
1.4.5 Insect cells
1.5 Market by Application
1.5.1 Global Eukaryotic Expression Systems Market Share by Application: 2020 VS 2026
1.5.2 Reagents
1.5.3 Expression vectors
1.5.4 Competent cells
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Eukaryotic Expression Systems Market Perspective (2015-2026)
2.2 Global Eukaryotic Expression Systems Growth Trends by Regions
2.2.1 Eukaryotic Expression Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Eukaryotic Expression Systems Historic Market Share by Regions (2015-2020)
2.2.3 Eukaryotic Expression Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Eukaryotic Expression Systems Market Growth Strategy
2.3.6 Primary Interviews with Key Eukaryotic Expression Systems Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Eukaryotic Expression Systems Players by Market Size
3.1.1 Global Top Eukaryotic Expression Systems Players by Revenue (2015-2020)
3.1.2 Global Eukaryotic Expression Systems Revenue Market Share by Players (2015-2020)
3.1.3 Global Eukaryotic Expression Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Eukaryotic Expression Systems Market Concentration Ratio
3.2.1 Global Eukaryotic Expression Systems Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Eukaryotic Expression Systems Revenue in 2019
3.3 Eukaryotic Expression Systems Key Players Head office and Area Served
3.4 Key Players Eukaryotic Expression Systems Product Solution and Service
3.5 Date of Enter into Eukaryotic Expression Systems Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Eukaryotic Expression Systems Historic Market Size by Type (2015-2020)
4.2 Global Eukaryotic Expression Systems Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Eukaryotic Expression Systems Market Size by Application (2015-2020)
5.2 Global Eukaryotic Expression Systems Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Eukaryotic Expression Systems Market Size (2015-2020)
6.2 Eukaryotic Expression Systems Key Players in North America (2019-2020)
6.3 North America Eukaryotic Expression Systems Market Size by Type (2015-2020)
6.4 North America Eukaryotic Expression Systems Market Size by Application (2015-2020)
7 Europe
7.1 Europe Eukaryotic Expression Systems Market Size (2015-2020)
7.2 Eukaryotic Expression Systems Key Players in Europe (2019-2020)
7.3 Europe Eukaryotic Expression Systems Market Size by Type (2015-2020)
7.4 Europe Eukaryotic Expression Systems Market Size by Application (2015-2020)
8 China
8.1 China Eukaryotic Expression Systems Market Size (2015-2020)
8.2 Eukaryotic Expression Systems Key Players in China (2019-2020)
8.3 China Eukaryotic Expression Systems Market Size by Type (2015-2020)
8.4 China Eukaryotic Expression Systems Market Size by Application (2015-2020)
9 Japan
9.1 Japan Eukaryotic Expression Systems Market Size (2015-2020)
9.2 Eukaryotic Expression Systems Key Players in Japan (2019-2020)
9.3 Japan Eukaryotic Expression Systems Market Size by Type (2015-2020)
9.4 Japan Eukaryotic Expression Systems Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Eukaryotic Expression Systems Market Size (2015-2020)
10.2 Eukaryotic Expression Systems Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Eukaryotic Expression Systems Market Size by Type (2015-2020)
10.4 Southeast Asia Eukaryotic Expression Systems Market Size by Application (2015-2020)
11 India
11.1 India Eukaryotic Expression Systems Market Size (2015-2020)
11.2 Eukaryotic Expression Systems Key Players in India (2019-2020)
11.3 India Eukaryotic Expression Systems Market Size by Type (2015-2020)
11.4 India Eukaryotic Expression Systems Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Eukaryotic Expression Systems Market Size (2015-2020)
12.2 Eukaryotic Expression Systems Key Players in Central & South America (2019-2020)
12.3 Central & South America Eukaryotic Expression Systems Market Size by Type (2015-2020)
12.4 Central & South America Eukaryotic Expression Systems Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Thermo Fisher
13.1.1 Thermo Fisher Company Details
13.1.2 Thermo Fisher Business Overview
13.1.3 Thermo Fisher Eukaryotic Expression Systems Introduction
13.1.4 Thermo Fisher Revenue in Eukaryotic Expression Systems Business (2015-2020))
13.1.5 Thermo Fisher Recent Development
13.2 Sigma Aldrich
13.2.1 Sigma Aldrich Company Details
13.2.2 Sigma Aldrich Business Overview
13.2.3 Sigma Aldrich Eukaryotic Expression Systems Introduction
13.2.4 Sigma Aldrich Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.2.5 Sigma Aldrich Recent Development
13.3 Jena Bioscience
13.3.1 Jena Bioscience Company Details
13.3.2 Jena Bioscience Business Overview
13.3.3 Jena Bioscience Eukaryotic Expression Systems Introduction
13.3.4 Jena Bioscience Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.3.5 Jena Bioscience Recent Development
13.4 New England Biolabs
13.4.1 New England Biolabs Company Details
13.4.2 New England Biolabs Business Overview
13.4.3 New England Biolabs Eukaryotic Expression Systems Introduction
13.4.4 New England Biolabs Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.4.5 New England Biolabs Recent Development
13.5 Takara Bio
13.5.1 Takara Bio Company Details
13.5.2 Takara Bio Business Overview
13.5.3 Takara Bio Eukaryotic Expression Systems Introduction
13.5.4 Takara Bio Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.5.5 Takara Bio Recent Development
13.6 Bio Rad
13.6.1 Bio Rad Company Details
13.6.2 Bio Rad Business Overview
13.6.3 Bio Rad Eukaryotic Expression Systems Introduction
13.6.4 Bio Rad Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.6.5 Bio Rad Recent Development
13.7 Promega
13.7.1 Promega Company Details
13.7.2 Promega Business Overview
13.7.3 Promega Eukaryotic Expression Systems Introduction
13.7.4 Promega Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.7.5 Promega Recent Development
13.8 Agilent
13.8.1 Agilent Company Details
13.8.2 Agilent Business Overview
13.8.3 Agilent Eukaryotic Expression Systems Introduction
13.8.4 Agilent Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.8.5 Agilent Recent Development
13.9 Merck Millipore
13.9.1 Merck Millipore Company Details
13.9.2 Merck Millipore Business Overview
13.9.3 Merck Millipore Eukaryotic Expression Systems Introduction
13.9.4 Merck Millipore Revenue in Eukaryotic Expression Systems Business (2015-2020)
13.9.5 Merck Millipore Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Eukaryotic Expression Systems Key Market Segments
Table 2. Key Players Covered: Ranking by Eukaryotic Expression Systems Revenue
Table 3. Ranking of Global Top Eukaryotic Expression Systems Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Eukaryotic Expression Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of MEL
Table 6. Key Players of COS
Table 7. Key Players of CHO
Table 8. Key Players of Insect cells
Table 9. Global Eukaryotic Expression Systems Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Eukaryotic Expression Systems Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Eukaryotic Expression Systems Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Eukaryotic Expression Systems Market Share by Regions (2015-2020)
Table 13. Global Eukaryotic Expression Systems Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Eukaryotic Expression Systems Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Eukaryotic Expression Systems Market Growth Strategy
Table 19. Main Points Interviewed from Key Eukaryotic Expression Systems Players
Table 20. Global Eukaryotic Expression Systems Revenue by Players (2015-2020) (Million US$)
Table 21. Global Eukaryotic Expression Systems Market Share by Players (2015-2020)
Table 22. Global Top Eukaryotic Expression Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eukaryotic Expression Systems as of 2019)
Table 23. Global Eukaryotic Expression Systems by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Eukaryotic Expression Systems Product Solution and Service
Table 26. Date of Enter into Eukaryotic Expression Systems Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Eukaryotic Expression Systems Market Size by Type (2015-2020) (Million US$)
Table 29. Global Eukaryotic Expression Systems Market Size Share by Type (2015-2020)
Table 30. Global Eukaryotic Expression Systems Revenue Market Share by Type (2021-2026)
Table 31. Global Eukaryotic Expression Systems Market Size Share by Application (2015-2020)
Table 32. Global Eukaryotic Expression Systems Market Size by Application (2015-2020) (Million US$)
Table 33. Global Eukaryotic Expression Systems Market Size Share by Application (2021-2026)
Table 34. North America Key Players Eukaryotic Expression Systems Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Eukaryotic Expression Systems Market Share (2019-2020)
Table 36. North America Eukaryotic Expression Systems Market Size by Type (2015-2020) (Million US$)
Table 37. North America Eukaryotic Expression Systems Market Share by Type (2015-2020)
Table 38. North America Eukaryotic Expression Systems Market Size by Application (2015-2020) (Million US$)
Table 39. North America Eukaryotic Expression Systems Market Share by Application (2015-2020)
Table 40. Europe Key Players Eukaryotic Expression Systems Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Eukaryotic Expression Systems Market Share (2019-2020)
Table 42. Europe Eukaryotic Expression Systems Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Eukaryotic Expression Systems Market Share by Type (2015-2020)
Table 44. Europe Eukaryotic Expression Systems Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Eukaryotic Expression Systems Market Share by Application (2015-2020)
Table 46. China Key Players Eukaryotic Expression Systems Revenue (2019-2020) (Million US$)
Table 47. China Key Players Eukaryotic Expression Systems Market Share (2019-2020)
Table 48. China Eukaryotic Expression Systems Market Size by Type (2015-2020) (Million US$)
Table 49. China Eukaryotic Expression Systems Market Share by Type (2015-2020)
Table 50. China Eukaryotic Expression Systems Market Size by Application (2015-2020) (Million US$)
Table 51. China Eukaryotic Expression Systems Market Share by Application (2015-2020)
Table 52. Japan Key Players Eukaryotic Expression Systems Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Eukaryotic Expression Systems Market Share (2019-2020)
Table 54. Japan Eukaryotic Expression Systems Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Eukaryotic Expression Systems Market Share by Type (2015-2020)
Table 56. Japan Eukaryotic Expression Systems Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Eukaryotic Expression Systems Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Eukaryotic Expression Systems Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Eukaryotic Expression Systems Market Share (2019-2020)
Table 60. Southeast Asia Eukaryotic Expression Systems Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Eukaryotic Expression Systems Market Share by Type (2015-2020)
Table 62. Southeast Asia Eukaryotic Expression Systems Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Eukaryotic Expression Systems Market Share by Application (2015-2020)
Table 64. India Key Players Eukaryotic Expression Systems Revenue (2019-2020) (Million US$)
Table 65. India Key Players Eukaryotic Expression Systems Market Share (2019-2020)
Table 66. India Eukaryotic Expression Systems Market Size by Type (2015-2020) (Million US$)
Table 67. India Eukaryotic Expression Systems Market Share by Type (2015-2020)
Table 68. India Eukaryotic Expression Systems Market Size by Application (2015-2020) (Million US$)
Table 69. India Eukaryotic Expression Systems Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Eukaryotic Expression Systems Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Eukaryotic Expression Systems Market Share (2019-2020)
Table 72. Central & South America Eukaryotic Expression Systems Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Eukaryotic Expression Systems Market Share by Type (2015-2020)
Table 74. Central & South America Eukaryotic Expression Systems Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Eukaryotic Expression Systems Market Share by Application (2015-2020)
Table 76. Thermo Fisher Company Details
Table 77. Thermo Fisher Business Overview
Table 78. Thermo Fisher Product
Table 79. Thermo Fisher Revenue in Eukaryotic Expression Systems Business (2015-2020) (Million US$)
Table 80. Thermo Fisher Recent Development
Table 81. Sigma Aldrich Company Details
Table 82. Sigma Aldrich Business Overview
Table 83. Sigma Aldrich Product
Table 84. Sigma Aldrich Revenue in Eukaryotic Expression Systems Business (2015-2020) (Million US$)
Table 85. Sigma Aldrich Recent Development
Table 86. Jena Bioscience Company Details
Table 87. Jena Bioscience Business Overview
Table 88. Jena Bioscience Product
Table 89. Jena Bioscience Revenue in Eukaryotic Expression Systems Business (2015-2020) (Million US$)
Table 90. Jena Bioscience Recent Development
Table 91. New England Biolabs Company Details
Table 92. New England Biolabs Business Overview
Table 93. New England Biolabs Product
Table 94. New England Biolabs Revenue in Eukaryotic Expression Systems Business (2015-2020) (Million US$)
Table 95. New England Biolabs Recent Development
Table 96. Takara Bio Company Details
Table 97. Takara Bio Business Overview
Table 98. Takara Bio Product
Table 99. Takara Bio Revenue in Eukaryotic Expression Systems Business (2015-2020) (Million US$)
Table 100. Takara Bio Recent Development
Table 101. Bio Rad Company Details
Table 102. Bio Rad Business Overview
Table 103. Bio Rad Product
Table 104. Bio Rad Revenue in Eukaryotic Expression Systems Business (2015-2020) (Million US$)
Table 105. Bio Rad Recent Development
Table 106. Promega Company Details
Table 107. Promega Business Overview
Table 108. Promega Product
Table 109. Promega Revenue in Eukaryotic Expression Systems Business (2015-2020) (Million US$)
Table 110. Promega Recent Development
Table 111. Agilent Business Overview
Table 112. Agilent Product
Table 113. Agilent Company Details
Table 114. Agilent Revenue in Eukaryotic Expression Systems Business (2015-2020) (Million US$)
Table 115. Agilent Recent Development
Table 116. Merck Millipore Company Details
Table 117. Merck Millipore Business Overview
Table 118. Merck Millipore Product
Table 119. Merck Millipore Revenue in Eukaryotic Expression Systems Business (2015-2020) (Million US$)
Table 120. Merck Millipore Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Eukaryotic Expression Systems Market Share by Type: 2020 VS 2026
Figure 2. MEL Features
Figure 3. COS Features
Figure 4. CHO Features
Figure 5. Insect cells Features
Figure 6. Global Eukaryotic Expression Systems Market Share by Application: 2020 VS 2026
Figure 7. Reagents Case Studies
Figure 8. Expression vectors Case Studies
Figure 9. Competent cells Case Studies
Figure 10. Eukaryotic Expression Systems Report Years Considered
Figure 11. Global Eukaryotic Expression Systems Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Eukaryotic Expression Systems Market Share by Regions: 2020 VS 2026
Figure 13. Global Eukaryotic Expression Systems Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Eukaryotic Expression Systems Market Share by Players in 2019
Figure 16. Global Top Eukaryotic Expression Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eukaryotic Expression Systems as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Eukaryotic Expression Systems Revenue in 2019
Figure 18. North America Eukaryotic Expression Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Eukaryotic Expression Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Eukaryotic Expression Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Eukaryotic Expression Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Eukaryotic Expression Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Eukaryotic Expression Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Eukaryotic Expression Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed